Silence Therapeutics Stock Target Price and Analyst Consensus
| SLN Stock | USD 5.11 0.32 5.89% |
The current analyst and expert consensus on Silence Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Silence Therapeutics target price consensus is 33.80 with 7 analyst opinions. Check out Macroaxis Advice on Silence Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Silence Therapeutics PLC analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Silence Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Silence Therapeutics. We strongly encourage you to use your own analysis of Silence Therapeutics PLC to validate this buy or sell advice. Silence Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Silence Therapeutics PLC target price to derive its highest and lowest estimates based on projected price volatility of 4.1089.
Lowest Forecast 30.76 | Highest Forecast 37.52 | Target Price 33.8 |
It's important to approach Silence Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Silence Therapeutics Target Price Consensus
Silence target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Silence Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Silence analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Silence stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Silence Therapeutics PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSilence Therapeutics Target Price Projection
Silence Therapeutics' current and average target prices are 5.11 and 33.80, respectively. The current price of Silence Therapeutics is the price at which Silence Therapeutics PLC is currently trading. On the other hand, Silence Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Silence Therapeutics Market Quote on 28th of January 2026
Target Price
Analyst Consensus On Silence Therapeutics Target Price
Silence Therapeutics Analyst Ratings
Silence Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Silence Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Silence Therapeutics' financials, market performance, and future outlook by experienced professionals. Silence Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Silence Therapeutics price targets
Silence Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Silence Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Silence Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Silence Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Silence Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Silence Therapeutics is a key component of Silence Therapeutics valuation and have some predictive power on the future returns of a Silence Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 100 shares | |
 | Diversified Assets Invested over 50 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Momentum Invested over 30 shares | |
 | Cash Cows Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Dividend Beast Invested over 30 shares | |
Check out Macroaxis Advice on Silence Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.